Villers-lès-Nancy,
PRESS RELEASE
New executive management team
- Proposal to appoint Denis SUPPLISSON as Pharmagest Group’s Chief Executive Officer
- Jean-Michel MONIN will be appointed Manager of the Europe Pharmacy Solutions Division
- Damien VALICON will be appointed Manager of the France Pharmacy Business Unit.
***
On
- Denis SUPPLISSON, current Deputy CEO and Manager of the Europe Pharmacy Solutions Division will become the Pharmagest Group’s Chief Executive Officer, replacing Dominique PAUTRAT, with effect from
22 April 2022 . - Jean-Michel MONIN, currently Manager of the France Pharmacy Business Unit, will then take over from Denis SUPPLISSON as Manager of the Europe Pharmacy Solutions Division as of
22 April 2022 . - Damien VALICON will join
Pharmagest Group on10 January 2022 , replacing Jean-Michel MONIN as Manager of the France Pharmacy Business Unit.
These proposed appointments will be submitted to the vote of the Board of Directors of the
***
Denis SUPPLISSON, 52,Linkedin - began his career in 1991 at
After returning to the head office in Nancy in 2009, Denis SUPPLISSON became the Manager of the France Pharmacy Business Unit and was appointed manager of the Europe Pharmacy Solutions Division in
Jean Michel MONIN, 53, LinkedIn - With a degree in political science (IEP Grenoble) and an MBA from
Damien VALICON, 51,LinkedIn - In addition to multiple experiences an entrepreneur, he has held various sales management positions as a distributor of medical equipment and solutions, notably for Trophy Radiologie. Since 2001, he has held senior management positions with healthcare solution providers and software companies. In 2011, he became Chief Business Development Officer of AxiSanté, a subsidiary of the German group,
Financial calendar:
- Publication of FY 2021 annual sales:
4 February 2022 (after the close of trading).
About
With more than 1,200 employees acting as “Citizens in the Service of Health and Well-Being”,
As a key contributor to the quality of healthcare and coordination between office-based private practice and hospitals,
Listed on Euronext Paris™ - Compartment A
Indexes: MSCI GLOBAL SMALL CAP - GAÏA Index 2020 - CAC® SMALL and CAC® All-Tradable
Included under the European Rising Tech label.
Eligible for the Deferred Settlement Service (“Service à Réglement Différé” - SRD) and equity savings accounts invested in small and mid caps (PEA-PME).
ISIN: FR 0012882389 – Reuters: PHA.PA – Bloomberg: PMGI FP
For all the latest news go to www.pharmagest.com
Follow
CONTACTS
Analyst and Investor Relations:
Chief Administrative and Financial Officer: Jean-Yves SAMSON
Tel. +33 (0)3 83 15 90 67 - jean-yves.samson@lacooperativewelcoop.com
Media Relations:
FIN’EXTENSO - Isabelle APRILE
Tel. +33 (0)1 39 97 61 22 - i.aprile@finextenso.fr
Attachment
- PHARMAGEST_PRESSRELEASE_20211203_new executive management team_en_US
© OMX, source